Results 31 to 40 of about 13,415 (150)
The triennial International Pigment Cell Conference (IPCC) [PDF]
arXiv, 2018 The International Federation of Pigment Cell Societies (IFPCS) held its XXIII triennial International Pigment Cell Conference (IPCC) in Denver, Colorado in August 2017. The goal of the summit was to provide a venue promoting a vibrant interchange among leading basic and clinical researchers working on leading-edge aspects of melanocyte biology and ...
arxiv
The Journal of Dermatology, EarlyView.Abstract Atopic dermatitis, psoriasis, alopecia areata, and vitiligo have been associated with comorbid conditions, including infections, malignancies, and cardiovascular diseases. This study evaluated the prevalence and incidence rates of these comorbidities in patients from Japan.
Yue Ma +6 more
wiley +1 more source
A Guide to Screening for Autoimmune Diseases in Patients With Vulvar Lichen Sclerosus
Australasian Journal of Dermatology, EarlyView.ABSTRACTBackgroundThe aetiology of vulvar lichen sclerosus (VLS) remains unknown. However, there is evidence that in addition to a genetic predisposition, autoimmunity contributes to the pathogenesis.ObjectivesThe objective of this study was to determine the prevalence of autoimmune disease and positive autoantibody serology in patients with VLS ...
Annabel Guttentag +5 more
wiley +1 more source
Australasian Journal of Dermatology, EarlyView.ABSTRACT Frontal fibrosing alopecia (FFA) is a form of cicatricial alopecia that is being increasingly diagnosed in recent years. It predominantly affects post‐menopausal women of various ethnic backgrounds, but cases have also been reported in pre‐menopausal women and rarely in men.
Adrienne Oxenham, Annabel Stevenson
wiley +1 more source
Australasian Journal of Dermatology, EarlyView.ABSTRACT HIV‐positive patients with psoriasis often face delays in accessing biologic therapies due to their exclusion from clinical trials and concerns about the impact of immunomodulatory drugs on viral replication. Anti‐IL‐23 therapies, such as risankizumab and guselkumab, have shown great promise thanks to their strong efficacy and favourable ...
V. Maione +10 more
wiley +1 more source
Treatment options for immune‐related adverse events associated with immune checkpoint inhibitors
British Journal of Pharmacology, EarlyView.Abstract The immunotherapy revolution with the use of immune checkpoint inhibitors (ICIs) started with the clinical use of the first ICI, ipilimumab, in 2011. Since then, the field of ICI therapy has rapidly expanded — with the FDA approval of 10 different ICI drugs so far and their incorporation into the therapeutic regimens of a range of malignancies.
Yu Hua Chen +3 more
wiley +1 more source
International Journal of Cosmetic Science, EarlyView.This study demonstrated that reducing dandruff's physical symptoms directly enhanced scalp and hair‐related emotional well‐being, and indirectly improved overall daily functioning. Addressing dandruff symptoms not only increases physical comfort but also positively impacts individuals' mental and emotional health, and their ability to function in their
A. Newton‐Fenner +6 more
wiley +1 more source